×

Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors

  • US 6,492,333 B1
  • Filed: 04/09/1999
  • Issued: 12/10/2002
  • Est. Priority Date: 04/09/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method to treat osteolytic bone destruction resulting from myeloma in a subject comprising administering to a subject in need of such treatment an effective amount of PSI or PPM-18.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×